News and features
Read the latest news and features about our world-leading research, discoveries, fundraising and philanthropy. If you want to keep updated on our news, you can follow us on social media or sign up for our Search newsletter.
If you’re a journalist and want to find out more, you can contact our media relations team.
Key signalling protein linked to aggressive cancers
Scientists have identified a protein which is associated with more aggressive breast, colorectal and ovarian cancers, which could be used to assist the diagnosis and development treatments for these cancers.
Partnering to Defeat Cancer: Babraham Research Campus hosts ICR networking event for our scientists and potential new commercial partners
The Institute of Cancer Research, London’s Enterprise Unit played host to scientists and possible future partners from the commercial sector to discuss opportunities to work together to defeat cancer.
High-precision radiotherapy can safely treat prostate cancer spread
Men with ‘high risk’ prostate cancer can safely receive high-dose radiotherapy to kill cancer cells that have spread into neighbouring lymph nodes, a new study reports.
New AI ‘shapeshift’ test identifies women with ‘very high risk’ ovarian cancer
Scientists have developed a new test that scans the shapes of tumour cells to pick out women with especially aggressive ovarian cancer, so treatment can be tailored to their needs.
The Royal Marsden’s Martin Gore dies unexpectedly
The ICR is shocked to learn that Professor Martin Gore, former Medical Director at The Royal Marsden, has died suddenly.
Protein found more in advanced prostate cancer could be key to preventing drug resistance
A cancer-driving protein is found in the tumours of men with advanced prostate cancer after treatment with hormone drugs, but rarely found in early-stage disease, a new study shows.
Land deal completes multimillion pound investment to make London Cancer Hub a reality
Plans to develop a world-leading cancer research hub in south London have taken a major step forward with the completion of the final stage in a £30 million investment in land.
Revolutionising the way we view childhood leukaemia
For decades, research at the ICR has transformed our understanding of childhood leukaemia and how it is treated. Now, research from Professor Sir Mel Greaves, Director of our Centre for Evolution and Cancer, could once more revolutionise the way we view the disease.
Pioneering scientist Mel Greaves is knighted after research to unveil cause of childhood leukaemia
Professor Mel Greaves has been knighted in the New Year Honours List for his pioneering and hugely influential research into childhood leukaemia.
-547x410.jpg?sfvrsn=c727183b_2 "Non-small cell lung cancer (photo Dr Ed Uthman-Yale Rosen-Flickr) 547x410")
Breast cancer drugs could help treat resistant lung cancers
A class of drugs used to treat certain breast cancers could help to tackle lung cancers that have become resistant to targeted therapies, suggests a new study in mice from the Francis Crick Institute and The Institute of Cancer Research, London
Practice-changing clinical trial reduces long-term radiotherapy side effects in women with breast cancer
Targeting or reducing the dose of radiotherapy for women with breast cancer after surgery can substantially reduce the side effects they experience, a large-scale clinical trial has shown.
HIFU: using ultrasound to heat and destroy tumours
Ultrasound has been used to detect cancer inside the body for over 70 years. But what if it could be used to treat cancer too? Conor McKeever, our Science Communications Officer, introduces an exciting technology developed by ICR scientists that does just that.
